CRISPR enzyme cartoon character cutting DNA strand, symbolizing Intellia Therapeutics' approach to curing genetic disease with humor and science.

🧬 Intellia Therapeutics (NTLA): CRISPR, Cures, and a Potential Biotech Blast-Off 💥

CRISPR meets comedy in this gene-edited deep dive into Intellia (NTLA). With Phase 3 trials for two potential one-time cures and a stock that’s already moving, this could be biotech’s next big inflection point. But risks? Still very real. 🧬📉💥

Read entire article